Keyword: Contract Development And Manufacturing Organizations (CDMO)

News

Bernard Pluta Appointed as President of Recipharm’s Development Services

22.02.2018 - Sweden-based drug developer and toll manufacturer Recipharm has appointed Bernard Pluta to lead its new global development organization, which is to be implemented during the first...

News

Lynn Lewis Appointed as SVP of Global Sales at Envigo

21.02.2018 - Envigo, a provider of nonclinical contract research services and research models, announced the appointment of Lynn Lewis to the position of Senior Vice President, Global Sales...

News

Celonic Acquires Glycotope Bio-manufacturing Facility

07.02.2018 - Swiss contract development and manufacturing organization (CDMO) Celonic has completed the acquisition of Glycotope’s bio-manufacturing facility in Heidelberg, Germany. Berlin...

Plant Construction & Process Technology

Both Positive and Negative Effects

02.10.2017 - Does the consolidation in the pharmaceutical industry affect CROs/CMOs, e.g. does it create a necessity for outsourcing partners to consolidate, too? Simon Edwards: It is somewhat...

News

CMC Biologics Hikes Capacity in Denmark

29.09.2017 - CMC Biologics, a wholly owned subsidiary of Japan’s Asahi Glass Company (AGC), will raise capacity at its site in Copenhagen, Denmark, to meet increasing demand for antibody drug...

Plant Construction & Process Technology

Ensuring Better Efficiency and Consistency

28.09.2017 - Does the consolidation in the pharmaceutical industry affect CROs/CMOs, e.g. does it create a necessity for outsourcing partners to consolidate, too? Mark Rogers: Between 1993 and...

Plant Construction & Process Technology

Earning a Large Chunk of the Cake

28.09.2017 - Daniel Mueller: The most obvious effect of consolidation in the pharmaceutical industry is a pronounced shift to those activities within the organization that provide the most...

Plant Construction & Process Technology

Pharma R&D Productivity Needs Improvement

28.09.2017 - Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will even intensify? Elliott Berger: With the ever-increasing share of...